Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Savara, Inc. - Common Stock (NQ:SVRA)

2.280 +0.040 (+1.79%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Savara, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
5 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... 
Via Benzinga
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Savara Inc.
Via Business Wire
5 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Protagenic Therapeutics (NASDAQ:PTIX... 
Via Benzinga
Savara Reports Second Quarter 2021 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
Savara Announces First Patient Dosed in Pivotal Phase 3 Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Trial
From Savara Inc.
Via Business Wire
Savara to Present at the Jefferies Virtual Healthcare Conference
From Savara Inc.
Via Business Wire
Savara to Present at the Oppenheimer Rare & Orphan Disease Virtual Summit
From Savara Inc.
Via Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Savara Inc.
Via Business Wire
Savara Reports First Quarter 2021 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
28 Stocks Moving in Wednesday's Pre-Market Session
Gainers Athenex, Inc. (NASDAQ: ATNX) shares rose 46.6% to $5.44 in pre-market trading after the company announced it acquired Kuur Therapeutics. iBio, Inc. (NYSE: IBIO) rose 29.5... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.